FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1985068195> ?p ?o ?g. }

• W1985068195 abstract "Treatment options for overactive bladder (OAB) with urinary urge incontinence (UUI) refractory to oral antimuscarinics include: botulinum toxin type A (BoNTA), sacral neuromodulation (SNM), and augmentation cystoplasty (AC). A standard treatment success metric that can be used in both clinical and economic evaluations of the above interventions has not emerged. Our objective was to conduct a literature review and synthesis of published measures of treatment success for OAB with UUI interventions and to identify a treatment success outcome. We performed a literature review of primary studies that used a definition of treatment success in the OAB with UUI population receiving BoNTA, SNM, or AC. The recommended success outcome was compared to generic and disease-specific health-related quality-of-life (HRQoL) measures using data from a BoNTA treatment study of neurogenic incontinent patients. Across all interventions, success outcomes included: complete continence (n = 23, 44%), ≥ 50% improvement in incontinence episodes (n = 16, 31%), and subjective improvement (n = 13, 25%). We recommend the OAB with UUI treatment success outcome of ≥ 50% improvement in incontinence episodes from baseline. Using data from a neurogenic BoNTA treatment study, the average change in the Incontinence Quality of Life questionnaire was 8.8 (95% CI: -4.7, 22.3) higher for those that succeeded (N = 25) versus those that failed (N = 26). The average change in the SF-6D preference score was 0.07 (95% CI: 0.02, 0.12) higher for those that succeeded versus those that failed. A treatment success definition that encompasses the many components of underlying OAB with UUI symptoms is currently not practical as a consequence of difficulties in measuring urgency. The treatment success outcome of ≥ 50% improvement in incontinence episodes was associated with a clinically meaningful improvement in disease-specific HRQoL for those with neurogenic OAB with UUI. The recommended success definition is less restrictive than a measure such as complete continence but includes patients who are satisfied with treatment and experience meaningful improvement in symptoms. A standardized measure of treatment success will be useful in clinical and health economic applications." @default.
• W1985068195 created "2016-06-24" @default.
• W1985068195 creator A5003031849 @default.
• W1985068195 creator A5032325756 @default.
• W1985068195 creator A5042646128 @default.
• W1985068195 creator A5045992434 @default.
• W1985068195 creator A5065870295 @default.
• W1985068195 creator A5087419260 @default.
• W1985068195 date "2009-11-20" @default.
• W1985068195 modified "2023-10-17" @default.
• W1985068195 title "Treatment success for overactive bladder with urinary urge incontinence refractory to oral antimuscarinics: a review of published evidence" @default.
• W1985068195 cites W1585489386 @default.
• W1985068195 cites W1878280580 @default.
• W1985068195 cites W190141409 @default.
• W1985068195 cites W1928285801 @default.
• W1985068195 cites W1965002957 @default.
• W1985068195 cites W1966491488 @default.
• W1985068195 cites W1968860914 @default.
• W1985068195 cites W1969154936 @default.
• W1985068195 cites W1972800450 @default.
• W1985068195 cites W1973849826 @default.
• W1985068195 cites W1976363592 @default.
• W1985068195 cites W1978157296 @default.
• W1985068195 cites W1980181710 @default.
• W1985068195 cites W1989913323 @default.
• W1985068195 cites W1993201124 @default.
• W1985068195 cites W1995640447 @default.
• W1985068195 cites W1996242258 @default.
• W1985068195 cites W1998995174 @default.
• W1985068195 cites W1999752640 @default.
• W1985068195 cites W2002037387 @default.
• W1985068195 cites W2008919972 @default.
• W1985068195 cites W2016354109 @default.
• W1985068195 cites W2017080933 @default.
• W1985068195 cites W2019362433 @default.
• W1985068195 cites W2019526772 @default.
• W1985068195 cites W2020726763 @default.
• W1985068195 cites W2020769178 @default.
• W1985068195 cites W2023442562 @default.
• W1985068195 cites W2025893414 @default.
• W1985068195 cites W2026234073 @default.
• W1985068195 cites W2029074543 @default.
• W1985068195 cites W2030058550 @default.
• W1985068195 cites W2034469261 @default.
• W1985068195 cites W2043653788 @default.
• W1985068195 cites W2044720944 @default.
• W1985068195 cites W2045798615 @default.
• W1985068195 cites W2048116394 @default.
• W1985068195 cites W2049610535 @default.
• W1985068195 cites W2058092191 @default.
• W1985068195 cites W2063307429 @default.
• W1985068195 cites W2064375999 @default.
• W1985068195 cites W2064471798 @default.
• W1985068195 cites W2071254580 @default.
• W1985068195 cites W2073899205 @default.
• W1985068195 cites W2079232828 @default.
• W1985068195 cites W2079262318 @default.
• W1985068195 cites W2081812660 @default.
• W1985068195 cites W2087487100 @default.
• W1985068195 cites W2090660395 @default.
• W1985068195 cites W2092052931 @default.
• W1985068195 cites W2094577227 @default.
• W1985068195 cites W2096869731 @default.
• W1985068195 cites W2098868027 @default.
• W1985068195 cites W2107593389 @default.
• W1985068195 cites W2127955638 @default.
• W1985068195 cites W2129986023 @default.
• W1985068195 cites W2131173377 @default.
• W1985068195 cites W2154133927 @default.
• W1985068195 cites W2166131657 @default.
• W1985068195 cites W2167713779 @default.
• W1985068195 cites W2172057491 @default.
• W1985068195 cites W2330724082 @default.
• W1985068195 cites W4231943573 @default.
• W1985068195 cites W4233218344 @default.
• W1985068195 cites W4256631357 @default.
• W1985068195 cites W4361868567 @default.
• W1985068195 doi "https://doi.org/10.1186/1471-2490-9-18" @default.
• W1985068195 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2788579" @default.
• W1985068195 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19930578" @default.
• W1985068195 hasPublicationYear "2009" @default.
• W1985068195 type Work @default.
• W1985068195 sameAs 1985068195 @default.
• W1985068195 citedByCount "24" @default.
• W1985068195 countsByYear W19850681952012 @default.
• W1985068195 countsByYear W19850681952013 @default.
• W1985068195 countsByYear W19850681952014 @default.
• W1985068195 countsByYear W19850681952015 @default.
• W1985068195 countsByYear W19850681952016 @default.
• W1985068195 countsByYear W19850681952017 @default.
• W1985068195 countsByYear W19850681952018 @default.
• W1985068195 countsByYear W19850681952019 @default.
• W1985068195 crossrefType "journal-article" @default.
• W1985068195 hasAuthorship W1985068195A5003031849 @default.
• W1985068195 hasAuthorship W1985068195A5032325756 @default.
• W1985068195 hasAuthorship W1985068195A5042646128 @default.
• W1985068195 hasAuthorship W1985068195A5045992434 @default.
• W1985068195 hasAuthorship W1985068195A5065870295 @default.
• W1985068195 hasAuthorship W1985068195A5087419260 @default.
• W1985068195 hasBestOaLocation W19850681951 @default.

• next